Guillermo Funes Rodríguez, president of the Concamin Health Industry Commission, said drug manufacturers have suffered very strong for a 9 billion pesos debt of the IMSS-Bienestar and other health entities in Mexico.
“It is estimated that in total they owe around 9 billion pesos to drug manufacturers, of which around 1,500 million pesos correspond to IMSS-Bienestar, and the rest is of the other institutions,” he said.
He added that debts come from 2023, so companies have “suffered strong.”
“We have a debt problem, which we are dealing with and (on Wednesday) there was a meeting between one of the associations, such as the Mexican Association of Pharmaceutical Laboratories (Amelaf), with the Undersecretary of Health and the IMSS-Bienestar Director General to remember Payment deadlines, ”said the businessman.
Lee: Thus the robbery of wheat, corn and soy was unleashed in the train that passes through Sonora and Sinaloa
“The other week there will be a meeting again to specify when, where and how payments will be made to drug manufacturers,” said the former president of the National Chamber of the Pharmaceutical Industry.
“If they do not pay our working capital and what they owe us, then we have a problem that companies are resisting a lot,” he said.
Lee: Emilio Azcárraga is proud to open the BMV door to sports teams
He explained that in order to solve debt problems, the intervention of Eduardo Clark García, Undersecretary of Health, and Alejandro Svarch, general director of the IMSS-Bienestar, has been very important.
“This begins to walk and will begin to solve the problem, which has been debts for several years,” he said.
In the short term, manufacturers will soon recover the payment and then the production process will be generated much better, he added.
‘There is medication shortages’
Funes Rodríguez said that there is a shortage of medicines, “we can even feel it every day.”
“All this was the product that health systems were not well made and change every year in the last five years, so all systems suffered an adjustment,” he said.
“Today there is a health system that is beginning to be implemented in the government of Claudia Sheinbum Pardo, but it requires time and support,” he said.
“We as industrialists are supporting the entire scheme, which is promoted by the Secretary of Health, David Kershenobich Stallnikowitz, and the Undersecretary of Health, Eduardo Clark to assemble it,” he said.
“The Ministry of Health has already made the first bidding for the purchase of medicines, of which a percentage was already assigned and at this time the second part of the purchases is running. As of March 4, the delivery of medicines will begin to flow, as the Undersecretary of Health said and we as entrepreneurs already have the production and at the time we win the second will begin to manufacture, ”he said.
“It hurts to say it, that there is a problem of shortage of medicines in Mexico, which is not attributable to the industry,” he said.
“The regularization of drug supply is not magical and regularization takes a couple of months,” he said.
Lee: Government and private sector figures collide on load transport robbery
“We as an industry produce medicines, but now they have asked us to deliver in different regions of the Mexican Republic and we will make an effort,” he said.
“The industry produces and someone has to distribute it, because we are not distributors. Distributing medications is not to grab Coca-Cola and Sabritas, ”he said.
“They ask you for 15 boxes of this medicine and 18 boxes of this other medicine in Sonora and they ask you the same in Mérida, imagine the cost of going to Sonora and then Mexico to deliver,” he said.
